Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Prévot

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
ACS Omega|April 1, 2020
Synthesis and Intracellular Uptake of Rhodamine-Nucleolipid Conjugates into a Nanoemulsion VehicleAnthony Cunha, Geoffrey Prévot, Yannick Mousli, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 13, 2021
Embracing nanomaterials' interactions with the innate immune systemAbraham J P Teunissen, Marianne E Burnett, Geoffrey Prévot, et al.
Nanoscale Advances|September 22, 2022
Multimodal optical contrast agents as new tools for monitoring and tuning nanoemulsion internalisation into cancer cells. From live cell imaging to <i>in vivo</i> imaging of tumoursGeoffrey Prévot, Talia Bsaibess, Jonathan Daniel, et al.
Data in Brief|November 22, 2017
Data on atherosclerosis specific antibody conjugation to nanoemulsionsGeoffrey Prévot, Martine Duonor-Cérutti, Mélusine Larivière, et al.
Data in Brief|November 22, 2017
Data on iron oxide core oil-in-water nanoemulsions for atherosclerosis imagingGeoffrey Prévot, Stéphane Mornet, Cyril Lorenzato, et al.
Bioconjugate Chemistry|November 15, 2018
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative DiseasesGeoffrey Prévot, Federico N Soria, Marie-Laure Thiolat, et al.
Aging Cell|March 23, 2022
Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal functionMarie-Laure Arotcarena, Federico N Soria, Anthony Cunha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2021
Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular DiseaseAbraham J P Teunissen, Mandy M T van Leent, Geoffrey Prévot, et al.
International Journal of Molecular Sciences|June 2, 2021
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to AtherosclerosisSamuel Bonnet, Geoffrey Prévot, Stéphane Mornet, et al.
International Journal of Pharmaceutics|September 14, 2017
Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imagingGeoffrey Prévot, Tina Kauss, Cyril Lorenzato, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
ACS Omega|April 1, 2020
Synthesis and Intracellular Uptake of Rhodamine-Nucleolipid Conjugates into a Nanoemulsion VehicleAnthony Cunha, Geoffrey Prévot, Yannick Mousli, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 13, 2021
Embracing nanomaterials' interactions with the innate immune systemAbraham J P Teunissen, Marianne E Burnett, Geoffrey Prévot, et al.
Nanoscale Advances|September 22, 2022
Multimodal optical contrast agents as new tools for monitoring and tuning nanoemulsion internalisation into cancer cells. From live cell imaging to <i>in vivo</i> imaging of tumoursGeoffrey Prévot, Talia Bsaibess, Jonathan Daniel, et al.
Data in Brief|November 22, 2017
Data on atherosclerosis specific antibody conjugation to nanoemulsionsGeoffrey Prévot, Martine Duonor-Cérutti, Mélusine Larivière, et al.
Data in Brief|November 22, 2017
Data on iron oxide core oil-in-water nanoemulsions for atherosclerosis imagingGeoffrey Prévot, Stéphane Mornet, Cyril Lorenzato, et al.
Bioconjugate Chemistry|November 15, 2018
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative DiseasesGeoffrey Prévot, Federico N Soria, Marie-Laure Thiolat, et al.
Aging Cell|March 23, 2022
Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal functionMarie-Laure Arotcarena, Federico N Soria, Anthony Cunha, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2021
Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular DiseaseAbraham J P Teunissen, Mandy M T van Leent, Geoffrey Prévot, et al.
International Journal of Molecular Sciences|June 2, 2021
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to AtherosclerosisSamuel Bonnet, Geoffrey Prévot, Stéphane Mornet, et al.
International Journal of Pharmaceutics|September 14, 2017
Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imagingGeoffrey Prévot, Tina Kauss, Cyril Lorenzato, et al.
Pageof 2